Anchoring Sheath
*Device currently in development
Our mission
Our mission is to develop less invasive devices to assist in complex congenital and structural heart procedures – in infants and adults.
We are doing this by working with leaders in coronary intervention and surgery to design practical solutions that make procedures safer and less traumatic – promoting faster and healthier long-term healing.
What is a Hybrid Procedure?
Management of complex congenital heart defects in the neonatal period has traditionally been surgical. In recent years, a hybrid approach has been developed, where surgeons and interventional cardiologists combine their expertise in correcting or palliating complex heart defects in neonates, infants and children; that cannot be adequately addressed by surgery or interventional catheterisation alone.
These procedures require specific functional devices, designed to optimise safety.
Safer Access for the Smallest Hearts
Our leadership team
Brian Bailey
Chief Executive Officer
Over 25 years of experience in cardiology device distribution and sales. Founder and CEO of Medilex Limited, a successful cardiology device distribution company (recently acquired). Has worked with leading international device manufacturers including Guidant, Boston Scientific, Abbott, Terumo, Bard, and Carbomedics.
Jonathan Akehurst
Chief Operating Officer
Over 30 years in Business Development & Marketing for pharma and medical devices. As Commercial Head of ClearStream Technologies PLC, where he led business expansion into 40+ international markets. As CEO of Cappella Medical Devices, leading device development from concept through regulatory approval and commercialisation.
Richard Paul
Chief Financial Officer
Richard is a seasoned Senior Business Leader and chartered accountant (FCA) with 35+ years of experience in corporate finance and M&A. He has successfully negotiated over 15 deals ranging from £2m to £200m across multiple continents, including a $265m North American asset disposal, £75m acquisition in Italy and Spain, and £65m principal refinancing.
Prof. Damien Kenny
Clinical Director
Consultant Congenital Cardiologist at Our Lady’s Children’s Hospital Crumlin and Mater Hospital, Dublin. Previously held an Honorary Consultant post in Paediatric Cardiac Transplantation and Heart Failure at Great Ormond Street Hospital, UK. Was Assistant Professor of Paediatrics and Internal Medicine at Rush University Medical Center, USA.
Prof. Kevin Walsh
Clinical Director
Cardiology Consultant specialising in congenital heart disease in both adult and paediatric populations. Clinical lead for the National Adult Congenital Heart Service at Mater Misericordia University Hospital, Dublin. Specialist in interventional cardiology and device occlusion of septal defects with pioneering work on current clinical devices. First-in-human implanter of several novel devices in complex cardiac procedures.
John Kelly
Research and Development
John has over 30 years of design/development experience in the medical devices sector. His career has seen him in pivotal technical leadership roles across both startups and established device companies, where he has guided the ideation and development of numerous innovative medical devices.